Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UChoose: Contraceptive Acceptability in Adolescents
NCT02404038Unknown
- Sponsor
- Desmond Tutu HIV Centre
- Start
- Jul 2015
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of norethisterone enanthate, etonogestrel + ethinyl estradiol and Triphasil in human immunodeficiency virus infection (HIV) (3 arms), sponsored by Desmond Tutu HIV Centre. Primary endpoint: Ortho Birth Control satisfaction assessment tool at 32 weeks. Status: unknown.
02
Drugs
norethisterone enanthateetonogestrel + ethinyl estradiolTriphasil
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02404038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02404038.